Compare top Immunotherapy doctors and prices in Israel. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
2
Israel
Reviews
14,000+
From real patients
Compare prices for Immunotherapy across top countries
Tap a country to view top doctors and prices
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Prof. Myriam Ben Arush is an internationally recognized specialist in pediatric oncology and bone marrow transplantation at Rambam Medical Center.
Specializing in radiotherapy and oncology, Dr. Karen Drumea brings focused expertise to immunotherapy at Rambam Medical Center.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
142 patients from Israel have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | Pediatric oncology cases | Internationally recognized for pediatric oncology and bone marrow transplantation. Awarded the Chevalier de la Legion d'Honneur and named among world's most caring doctors. | Israel | Price on request
| ||
| #2 | Immunotherapy integration with radiotherapy | Specializes in combining radiotherapy with immunotherapy for enhanced treatment outcomes. Works at Rambam Medical Center. | Israel | Price on request
|
Patients can join clinical trials under the supervision of Israeli immunotherapy doctors at JCI-accredited centers like Sourasky Medical Center. Leading oncologists serve as principal investigators for global trials. These specialists manage access to experimental treatments like CAR T-cell therapy and tumor-infiltrating lymphocytes for international patients.
Bookimed Expert Insight: Data shows that Israeli oncology leadership often holds dual roles in international research bodies like ESMO and ASCO. For example, Dr. Ari Raphael acts as a Molecular Tumor Board moderator. This high level of integration means patients may access the same immunotherapy protocols found in the US or Europe but with significantly faster enrollment timelines, often within one month.
Patient Consensus: Patients note that Israeli doctors are very welcoming to international participants, even those without local insurance. Many were surprised by how quickly they could start a Phase II trial compared to the long waits in their home countries. They often stay in nearby hotels and find the coordination with medical teams to be direct and efficient.
Leading immunotherapy specialists in Israel include Prof. Dr. Ofer Merimsky and Dr. Ido Wolf at Sourasky Medical Center. These experts hold prestigious European Society for Medical Oncology (ESMO) roles. They lead advanced clinical trials for melanoma, sarcoma, and lung cancer using modern genomic profiling.
Bookimed Expert Insight: Data shows a strong trend of specialization within immunotherapy in Israel. For example, Dr. Ari Raphael focuses on genomic profiling for lung cancer at Sourasky. Meanwhile, Dr. Sonnenblick Amir specializes in Keytruda for breast cancer. Families seeking pediatric care often choose Dr. Dror Levin, who trained at Italy's top bone oncology center. Consultations with these experts typically range from $750 to $1,050.
Patient Consensus: Patients note that Israeli centers offer much faster access to clinical trials than other countries. Many were surprised by the multidisciplinary approach where teams of specialists collaborate on one case. Those traveling to Jerusalem or Tel Aviv feel more involved in their treatment decisions because of the clear communication from the medical staff.
Israeli immunotherapy doctors identify candidates through molecular biomarker testing and advanced genomic profiling. Specialists use next-generation sequencing to find mutations like MSI-H or high tumor mutational burden. They also assess physical fitness using the ECOG scale to confirm a patient can tolerate intensive treatment.
Bookimed Expert Insight: Israeli oncology centers prioritize rapid diagnostics alongside leading researchers like Dr. Ari Raphael at Sourasky Medical Center. He moderates the Molecular Tumor Board and utilizes liquid biopsies to monitor T-cell responses. This integration of real-time genomic data allows doctors to approve immunotherapy for complex cases faster than many other international facilities.
Patient Consensus: Patients note that doctors require thorough bloodwork and PET/CT scans before starting any therapy. Many found that having high PD-L1 levels or specific mutations was the key to getting treatment approval. They often feel relieved by how quickly tumor sequencing results come back in Israel.
Israeli immunotherapy doctors require a detailed medical dossier to determine eligibility for advanced biologics. Patients must provide pathology reports, recent PET-CT or MRI scans (DICOM format), and documented treatment history in English. These records help specialists like Dr. Ido Wolf evaluate tumor markers before recommending specific immunotherapy protocols.
Bookimed Expert Insight: While basic pathology is standard, Israeli specialists like Dr. Ari Raphael at Sourasky Medical Center prioritize genomic profiling and liquid biopsy data. Our data shows that submitting MSI-high or dMMR status from NGS testing significantly speeds up the consultation approval process. Patients should also prepare to send original pathological blocks if requested for local laboratory verification.
Patient Consensus: Patients note it is important to have all files translated into English well in advance. Many were surprised that doctors required complete PDF submissions via secure portals at least two weeks before the meeting. They say having a clear log of how they responded to past chemo made the initial talk much more productive.
Israeli immunotherapy doctors provide extensive access to clinical trials for advanced cancer care. Specialists at centers like Sourasky Medical Center (Ichilov) serve as principal investigators for phase 1-3 trials. These studies evaluate next-generation therapies like pembrolizumab, TIL-cell therapy, and personalized cancer vaccines.
Bookimed Expert Insight: Data shows that top Israeli oncologists often hold dual roles as hospital department heads and principal investigators for global pharmaceutical trials. For example, Dr. Ari Raphael at Sourasky Medical Center (Ichilov) manages pharmaceutical phase I-III studies while moderating molecular tumor boards. This dual expertise allows them to match patients with specific trials based on complex genomic profiling and liquid biopsy results.
Patient Consensus: Patients note that it is vital to ask about trials early because eligibility can change as the disease progresses. Many were surprised to find they could access international studies from companies like Merck or Roche in Tel Aviv. They often find that private consultations, starting from $750 with experts like Dr. Irina Stepfansky, help speed up the eligibility review process.
You can start your immunotherapy journey with a remote consultation before traveling to Israel. This step allows top oncologists to review your medical records and confirm if advanced treatments like Keytruda or specialized protocols are suitable for your specific diagnosis.
Bookimed Expert Insight: Data shows that choosing a doctor with a dual background in research and clinical practice, like Dr. Irina Stepfansky or Dr. Ofer Merimsky at Sourasky Medical Center, provides a significant advantage. These specialists often lead phase I-III clinical trials, meaning they can offer insights into emerging immunotherapy protocols during your remote session that may not be available in standard hospital settings. Consulting with a specialist who holds a consultation for approximately $750 to $950 can save you from unnecessary travel if your case requires a different therapeutic approach.
Patient Consensus: Patients mention that a video call with their doctor made them feel much more at ease before flying. They noted it was helpful to have a clear plan and a familiar face waiting for them at the clinic.